Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Russian Peptide is a biotechnology company headquartered in Saint Petersburg, Russia, that specializes in the research, development, and production of peptide-based compounds. The company operates as both a product developer and a contract manufacturing organization, providing high-purity peptides for the pharmaceutical, cosmetic, and research industries. Their extensive portfolio includes bioregulatory peptides such as Epitalon and Semax, which are targeted toward anti-aging, neuroprotection, and metabolic health. Russian Peptide maintains advanced laboratory facilities for custom peptide synthesis, allowing for the creation of complex sequences and modified peptides. By integrating scientific research with industrial production, the company supports the global life sciences community in exploring the therapeutic potential of peptide molecules. Their services also encompass chemical analysis and quality control to ensure the stability and efficacy of their synthesized products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Russian Peptide.